Literature DB >> 27218672

Endovascular treatment of Budd-Chiari syndrome: Single center experience.

Krantikumar Rathod1, Hemant Deshmukh1, Akash Shukla2, Bhavesh Popat1, Ankur Pandey1, Amit Gupte2, Deepak Kumar Gupta2, Shobna J Bhatia2.   

Abstract

BACKGROUND AND AIM: Percutaneous radiologic interventions are increasingly being used in management of Budd-Chiari syndrome (BCS). Minimal invasive approach has resulted in excellent long-term outcomes. We evaluated the treatment efficacy and safety of radiological intervention in patients with BCS.
METHODS: Between January 2008 and June 2014, 190 patients with BCS underwent endovascular procedures (hepatic vein, collateral vein or inferior vena cava [IVC] plasty with or without stenting, or transjugular intrahepatic portosystemic shunting [TIPSS]). Clinical features, biochemical profile, and stent patency were monitored pre-procedure and post-procedure, and for a median duration of 42 (12-88) months.
RESULTS: Of 190 patients (mean [SD] age = 26.9 [11.5] years; 102 men), imaging revealed hepatic vein obstruction in 147 patients, IVC obstruction in 40 patients, and concomitant hepatic vein and IVC obstruction in three patients. At presentation, the radiological interventions included hepatic vein plasty/stenting in 38 patients, collateral vein stenting in three patients, IVC plasty/stenting in 40 patients, both IVC and hepatic vein stenting in three patients, and TIPSS in 106 patients. Response was seen in 153 patients (80.5%). Repeat interventions were required in 19 patients (10.0%). Complications were noted in nine patients (4.7%).
CONCLUSION: Our study demonstrates that venous recanalization and TIPSS for BCS are safe and efficacious.
© 2016 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Budd-Chiari syndrome; TIPSS; endovascular procedures

Mesh:

Year:  2017        PMID: 27218672     DOI: 10.1111/jgh.13456

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  15 in total

1.  Budd-Chiari Syndrome With Spontaneous Intrahepatic Portosystemic Shunts: A Case Series.

Authors:  Pratin Bhatt; Deepak K Gupta; Dhiraj Agrawal; Hemant Deshmukh; Krantikumar Rathod; Akash Shukla
Journal:  J Clin Exp Hepatol       Date:  2018-08-25

2.  Cirrhotic cardiomyopathy is less prevalent in patients with Budd-Chiari syndrome than cirrhosis of liver.

Authors:  Akash Shukla; Pratin Bhatt; Deepak Kumar Gupta; Tejas Modi; Jatin Patel; Milind Phadke; Krantikumar Rathod; Megha Meshram; S J Bhatia
Journal:  Indian J Gastroenterol       Date:  2018-01-24

3.  Budd-Chiari syndrome has different presentations and disease severity during adolescence.

Authors:  Akash Shukla; Pratin Bhatt; Deepak Kumar Gupta; Tejas Modi; Jatin Patel; Amit Gupte; Megha Meshram; Shobna Bhatia
Journal:  Hepatol Int       Date:  2018-07-03       Impact factor: 6.047

Review 4.  Budd-Chiari syndrome/hepatic venous outflow tract obstruction.

Authors:  Dominique-Charles Valla
Journal:  Hepatol Int       Date:  2017-07-06       Impact factor: 6.047

5.  Presence of Ascites at Presentation is Associated With Absence of Long-Term Response Amongst Patients With Budd-Chiari Syndrome When Treated With Medical Therapy Alone: A Single Centre Real-Life Experience.

Authors:  Dhiraj Agrawal; Deepak Gupta; Rohit Nathani; Prashant Dhore; Megha Meshram; Shobna J Bhatia; Akash Shukla
Journal:  J Clin Exp Hepatol       Date:  2021-11-03

6.  Liver Transplantation and Budd-Chiari Syndrome: When the Cause Becomes the Solution.

Authors:  Nikolaos Garmpis; Christos Damaskos; Dionysios Prevezanos; Anna Garmpi; Vasiliki E Georgakopoulou; Efstathios A Antoniou; Gregory Kouraklis; Dimitrios Dimitroulis
Journal:  Maedica (Bucur)       Date:  2022-06

7.  Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL).

Authors:  Akash Shukla; Ananta Shreshtha; Amar Mukund; Chhagan Bihari; C E Eapen; Guohong Han; Hemant Deshmukh; Ian Homer Y Cua; Cosmas Rinaldi Adithya Lesmana; Mamun Al Meshtab; Masayoshi Kage; Roongruedee Chaiteeraki; Sombat Treeprasertsuk; Suprabhat Giri; Sundeep Punamiya; Valerie Paradis; Xingshun Qi; Yasuhiko Sugawara; Zaigham Abbas; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2021-07-08       Impact factor: 6.047

8.  Budd-Chiari syndrome in China: A 30-year retrospective study on survival from a single center.

Authors:  Wei Zhang; Qiao-Zheng Wang; Xiao-Wei Chen; Hong-Shan Zhong; Xi-Tong Zhang; Xu-Dong Chen; Ke Xu
Journal:  World J Gastroenterol       Date:  2018-03-14       Impact factor: 5.742

Review 9.  An Update on the Management of Budd-Chiari Syndrome.

Authors:  A Sharma; S N Keshava; A Eapen; E Elias; C E Eapen
Journal:  Dig Dis Sci       Date:  2020-07-20       Impact factor: 3.199

10.  Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension.

Authors:  Dhiraj Tripathi; Adrian J Stanley; Peter C Hayes; Simon Travis; Matthew J Armstrong; Emmanuel A Tsochatzis; Ian A Rowe; Nicholas Roslund; Hamish Ireland; Mandy Lomax; Joanne A Leithead; Homoyon Mehrzad; Richard J Aspinall; Joanne McDonagh; David Patch
Journal:  Gut       Date:  2020-02-29       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.